David Chappell

3.1k total citations
39 papers, 2.5k citations indexed

About

David Chappell is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, David Chappell has authored 39 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Surgery, 14 papers in Endocrinology, Diabetes and Metabolism and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in David Chappell's work include Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Lipid metabolism and disorders (11 papers). David Chappell is often cited by papers focused on Lipoproteins and Cardiovascular Health (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Lipid metabolism and disorders (11 papers). David Chappell collaborates with scholars based in United States, Sweden and Norway. David Chappell's co-authors include Dudley K. Strickland, Glenna L. Fry, W. Scott Argraves, Jheem D. Medh, Michelle Waknitz, Marc W. Pladet, Per‐Henrik Iverius, Maria Z. Kounnas, Frank M. Faraci and Kathryn G. Lamping and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

David Chappell

39 papers receiving 2.4k citations

Peers

Countries citing papers authored by David Chappell

Since Specialization

Citations

This map shows the geographic impact of David Chappell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chappell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chappell more than expected).

Fields of papers citing papers by David Chappell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chappell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chappell. The network helps show where David Chappell may publish in the future.

Co-authorship network of co-authors of David Chappell

This figure shows the co-authorship network connecting the top 25 collaborators of David Chappell. A scholar is included among the top collaborators of David Chappell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chappell. David Chappell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Enterprise Service Bus: Theory in Practice 2004 ·David Chappell	72
2	Macrophage-Specific Expression of Human Lipoprotein Lipase Accelerates Atherosclerosis in Transgenic Apolipoprotein E Knockout Mice but Not in C57BL/6 Mice 2001 ·Arteriosclerosis Thrombosis and Vascular Biology ·Katina M. Wilson, Glenna L. Fry, David Chappell, Curt D. Sigmund, Jheem D. Medh	76
3	Lipoprotein lipase- and hepatic triglyceride lipase-promoted very low density lipoprotein degradation proceeds via an apolipoprotein E-dependent mechanism 2000 ·Journal of Lipid Research ·Jheem D. Medh, Glenna L. Fry, (unknown), (unknown), Howard Wong, David Chappell	29
4	Receptor-mediated mechanisms of lipoprotein remnant catabolism 1998 ·Progress in Lipid Research ·David Chappell, Jheem D. Medh	54
5	Atherosclerosis, Vascular Remodeling, and Impairment of Endothelium-Dependent Relaxation in Genetically Altered Hyperlipidemic Mice 1997 ·Arteriosclerosis Thrombosis and Vascular Biology ·(unknown), Donald D. Heistad, David Chappell, Kathryn G. Lamping, Frank M. Faraci	147
6	Very low density lipoproteins stimulate surfactant lipid synthesis in vitro. 1997 ·Journal of Clinical Investigation ·Rama K. Mallampalli, (unknown), (unknown), David Chappell	21
7	Lipoprotein Lipase Binds to Low Density Lipoprotein Receptors and Induces Receptor-mediated Catabolism of Very Low Density Lipoproteins 1996 ·Journal of Biological Chemistry ·Jheem D. Medh, (unknown), Glenna L. Fry, (unknown), Mark E. Andracki, Ituro Inoue, Jean-Marc Lalouel, Dudley K. Strickland, David Chappell	72
8	The Very Low Density Lipoprotein Receptor Mediates the Cellular Catabolism of Lipoprotein Lipase and Urokinase-Plasminogen Activator Inhibitor Type I Complexes 1995 ·Journal of Biological Chemistry ·Kelley M. Argraves, Frances D. Battey, Colin D. MacCalman, Keith R. McCrae, Mats Gåfvels, Karen Kozarsky, David Chappell, Jerome F. Strauss, Dudley K. Strickland	136
9	The Cellular Internalization and Degradation of Hepatic Lipase Is Mediated by Low Density Lipoprotein Receptor-related Protein and Requires Cell Surface Proteoglycans 1995 ·Journal of Biological Chemistry ·Maria Z. Kounnas, David Chappell, Howard Wong, W. Scott Argraves, Dudley K. Strickland	107
10	Glycoprotein 330/Low Density Lipoprotein Receptor-related Protein-2 Mediates Endocytosis of Low Density Lipoproteins via Interaction with Apolipoprotein B100 1995 ·Journal of Biological Chemistry ·Steingrimur Stefansson, David Chappell, Kelley M. Argraves, Dudley K. Strickland, W. Scott Argraves	88
11	The 39-kDa Receptor-associated Protein Modulates Lipoprotein Catabolism by Binding to LDL Receptors 1995 ·Journal of Biological Chemistry ·Jheem D. Medh, Glenna L. Fry, (unknown), Marc W. Pladet, Dudley K. Strickland, David Chappell	109
12	The Carboxy‐Terminal Domain of Lipoprotein Lipase Induces Cellular Catabolism of Normal Very Low Density Lipoproteins via the Low Density Lipoprotein Receptor—Related Protein/α₂‐Macroglobulin Receptor 1994 ·Annals of the New York Academy of Sciences ·David Chappell, Ituro Inoue, Glenna L. Fry, Marc W. Pladet, Per‐Henrik Iverius, Jean‐Marc Lalouel, Dudley K. Strickland	8
13	The carboxyl-terminal domain of lipoprotein lipase binds to the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor (LRP) and mediates binding of normal very low density lipoproteins to LRP. 1994 ·Journal of Biological Chemistry ·Suzanne E. Williams, Ikuo Inoue, Hoanh Tran, Glenna L. Fry, Marc W. Pladet, Per‐Henrik Iverius, Jean-Marc Lalouel, David Chappell, Dudley K. Strickland	104
14	Evidence for isomerization during binding of apolipoprotein-B100 to low density lipoprotein receptors. 1992 ·Journal of Biological Chemistry ·David Chappell, Glenna L. Fry, Michelle Waknitz, (unknown)	21
15	The low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. 1992 ·Journal of Biological Chemistry ·David Chappell, Glenna L. Fry, Michelle Waknitz, Per‐Henrik Iverius, Suzanne E. Williams, Dudley K. Strickland	140
16	Familial Hypobetalipoproteinemia Associated with a Mutant Species of Apolipoprotein B (B-46) 1989 ·New England Journal of Medicine ·Stephen G. Young, S Hubl, David Chappell, Richard S. Smith, (unknown), Steven M. Snyder, Joseph Terdiman	63
17	High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia). 1989 ·Journal of Clinical Investigation ·David Chappell	21
18	Pre-beta-very low density lipoproteins as precursors of beta-very low density lipoproteins. A model for the pathogenesis of familial dysbetalipoproteinemia (type III hyperlipoproteinemia). 1988 ·Journal of Clinical Investigation ·David Chappell	24
19	Role of apolipoprotein E in the lipolytic conversion of beta-very low density lipoproteins to low density lipoproteins in type III hyperlipoproteinemia. 1984 ·Proceedings of the National Academy of Sciences ·Christian Ehnholm, Robert W. Mahley, David Chappell, Karl H. Weisgraber, E H Ludwig, J L Witztum	120
20	Hypokalemia and diabetes mellitus 1983 ·The American Journal of Medicine ·Carl Grünfeld, David Chappell	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact